Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perspective Therapeutics Inc CATX

Healthcare Biotechnology
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that... see more

Recent & Breaking News (NYSEAM:CATX)

Isoray Reschedules Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call to September 22, 2021 Due to Conference Provider Technical Issues

GlobeNewswire September 21, 2021

Isoray Announces Fourth Quarter and Full-Year Fiscal Year End 2021 Financial Results

GlobeNewswire September 21, 2021

Isoray To Announce Fourth Quarter and Fiscal Year End 2021 Financial Results on September 21, 2021

GlobeNewswire September 9, 2021

Isoray Announces Third Quarter Fiscal 2021 Financial Results

GlobeNewswire May 13, 2021

Isoray To Announce Third Quarter Fiscal 2021 Financial Results on May 13, 2021

GlobeNewswire April 29, 2021

Isoray Announces the Appointment of Donna Fort as Vice President Sales and Marketing

GlobeNewswire April 13, 2021

University Hospitals Cleveland Medical Center Pilot Study Shows Promise for High-Risk Recurrent Head and Neck Cancer Treatment with Cesium-131 and Surgical Resection

GlobeNewswire March 31, 2021

Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference

GlobeNewswire March 3, 2021

Isoray Announces the Appointment of Lisa Lauer As Vice President Business Development

GlobeNewswire February 16, 2021

Isoray Announces Second Quarter Fiscal 2021 Financial Results

GlobeNewswire February 9, 2021

Isoray To Announce Second Quarter Fiscal 2021 Financial Results on February 9, 2021

GlobeNewswire February 5, 2021

Isoray Announces Pricing of $45 Million Public Offering

GlobeNewswire February 4, 2021

Isoray Announces Proposed Underwritten Public Offering

GlobeNewswire February 3, 2021

Isoray to Present at the H.C. Wainwright BioConnect 2021 Conference

GlobeNewswire January 7, 2021

C4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray's Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer

GlobeNewswire January 5, 2021

Isoray's Cesium-131 Spotlighted in Multiple Presentations at ASTRO

GlobeNewswire November 24, 2020

Isoray Announces First Quarter Fiscal 2021 Financial Results

GlobeNewswire November 10, 2020

Isoray To Announce First Quarter Fiscal 2021 Financial Results on November 10, 2020

GlobeNewswire November 2, 2020

Isoray, Inc. Announces Pricing of $9.5 Million Public Offering

GlobeNewswire October 20, 2020

Isoray, Inc. Announces Proposed Underwritten Public Offering

GlobeNewswire October 19, 2020